SlideShare uma empresa Scribd logo
1 de 32
PATHOGENESIS  BOTH  :  insulin deficiency   +   elevation of counterregulatory hormones  (glucagon, catecholamines, cortisol, growth hormone) ↓ Increase hepatic & renal glucose production Impaired glucose utilization in peripheral tissues ↓ Hyperglycemia & increase plasma osmolality
PATHOGENESIS DKA :  release of free fatty acids (lipolysis) ↓ Hepatic fatty acid oxidation to ketone bodies (β-hydroxybutyrate & acetoacetate) ↓ Ketonemia & metabolic acidosis
PATHOGENESIS HHS :  Plasma insulin  – inadequate for glucose utilization  ‒ adequate to prevent lipolysis & ketogenesis DKA & HHS :    ― magnitude of dehydration   ― degree of ketosis (& acidosis)
PRECIPITATING  FACTORS ● Infection ● Cerebrovascular accident ● Alcohol abuse ● Pancreatitis ● Myocardial infarction ● Trauma ● Drugs e.g. steroids, thiazides, sympathomimetic   agents (dobutamine & terbutaline) ● Stop/inadequate insulin in DM type I ● Elderly with new-onset DM
DIAGNOSIS History & physical examination : Process :       - HHS : over several days to weeks      - DKA : much shorter (typically < 24 hr) 2) Classical clinical picture of both :      - polyuria                 - polydipsia      - polyphagia            - weight loss      - vomitting               - abdominal pain (DKA)      - dehydration           - weakness      - clouding of sensoria    - coma
DIAGNOSIS 3) Physical finding :     - poor skin tugor     - Kussmaul respiration (DKA)     - tachycardia                - hypotension     - alteration of conscious (lethargy  coma :HHS)     - emesis (coffee-ground)     - hypothermia (peripheral vasodilatation)     - abdominal pain        (DKA : Rx dehydration & metabolic  acidosis)
LABORATORY  FINDINGS : 1)Initial lab :      - BS, BUN, Cr, serum ketone     - electrolyte (with calculated anion gap)  •pseudohypoNa : osmotic gradient from hypergly.         • true hypoNa  from severe hyperTG        • hyperK  from insulin deficiency,hypotonicity&  acidemia(cell shift)      - osmolality : ≥ 320 mOsm/kg  stupor/coma         = 2 [measured Na (mEq/L) + BS (mg/dl)/18)      - CBC with diff count (leukocytosisὰ serum ketone)      - U/A, urine ketone
LABORATORY  FINDINGS : 1)Initial lab:      - EKG       - HbA1C : acute or chronic poor control 2) Suspected infection :       - bacterial cultures of urine,blood & throat ,etc       - CxR       - abdominal pain : pancreatitis  serum lipase         (DKA : increase serum amylase & liver enz )
DIFFERENTIAL  DIAGNOSIS : Ketoacidosis:         - Starvation ketosis        - Alcoholic ketoacidosis          mildly elevation BS (rarely > 250 mg/dl)          serum HCO3 not < 18 mEQ/L 2) High-anion gap metabolic acidosis :      - Lactic acidosis (Ix : serum lactate)      - drugs :          • salicylate (Ix : serum salicylate),          • methanol (Ix : serum methanol)         • ethylene glycol            (Ix : U/A-calcium oxalate &hippurate crystal),
DIFFERENTIAL  DIAGNOSIS :  2) High-anion gap metabolic  acidosis :      - paraldehyde        (strong odor breathing-osmolar gap-          anion gap acidosis)      - Chronic renal failure (hyperchloremic acidosis)
TREATMENT : Correction of dehydration, hyeprglycemia & E’lyte imbalance 2) Correct precipitating factor 3) Guideline for management
Fluid therapy : Adult patients :      - initial fluid Rx in no cardiac compromise :          0.9%NaCl  ≥ 15-20 ml/kg/hr  in 1st hour         ( ~ 1-1.5 L )      - subsequent  choice for fluid depend on         hydration, serum E’lyte & urine output          • if N/↑serum Na  0.45% NaCl 4 – 14 ml/kg          • if ↓ serum Na  0.9% NaCl      - monitor BP; fluid input/output ; clinical exam ; sermoosmolality not > 3 mOsm/kg/H2O/hr      - fluid replacement correct deficit in 24 hr
FLUID  THERAPY : 2) Pediatric patients (< 20 yrs) :      - 1st hr : 0.9%NaCl  10-20 ml/hr         ( not > 50 ml/kg in first 4 hr of therapy )       - Continued fluid therapy = fluid deficit in 48 hr or        1.5 times of 24 hr maintenance  or 5 ml/kg/hr             • 0.45-0.9% NaCl rate           • ↓ osmolality not > 3 mOsm/kg/hr      - serum glucose = 250 mg/dl             change 5%DN/2 or 5%D/N/3 with potassium
INSULIN  THERAPY : Not mild DKA :      Rx of choice = regular insulin continuous IV infusion     Exclude hypoK (< 3.3 mEq/l)      Start regular insulin 0.15 units/kg iv bolus       (iv bolus nit recommend in pediatric)     Cont. infusion 0.1 units/kg/hr (5-7 units/hr in adult)      Aim decrease BS 50-75 mg/dl/hr     If  in 1st hr BS not decrease > 50 mg/dl            • check hydration           • double dose insulin infusion every hr
INSULIN  THERAPY : when BS = 250 mg/dl in DKA  or                  = 300 mg/dl in HHS      • ↓ insulin infusion rate = 0.05 - 0.1 unit/kg/hr         (3-6 units/hr)      • 5-10% Dextrose Keep until   acidosis in DKA                     mental status  hyperosmolarity  in HHS        resolve
INSULIN  THERAPY : Ketonemia    • longer ot clear than hyperglycemia    • monitor by measure serum β-OHB      during Rx β-OHB  acetoacetic ȃ  worse ketosis      then not use urine / serum ketone level for Rx During Rx : monitor serum E’lyte , BS, BUN, Cr,  osmolality & venous pH (for DKA) q 2-4 hr                    ( venous pH < arterial pH = 0.03 units )                    anion gap  resolution of acidosis
Mild DKA : Regular insulin SC or IM q 1 hr     - priming dose of RI = 0.4 – 0.6 unit/kg          • half     IV bolus          • half     SC  or  IM     - then RI 0.1 unit/kg/hr  SC  or  IM
CRITERIA  FOR  RESOLUTION  OF  DKA : ●  Glucose  <  200  mg/dl ●  Serum bicarbonate  ≥  18  mEq/l ●   Venous pH   >  7.3 When DKA resolve  If NPO :          • continue IV insulin & fluid replacement         • RI sc q 4 hr            (RI 5 unit / BS 50 mg/dl if BS > 150 mg/dl             until RI 20 unit for BS ≥ 300 mg/dl)
When DKA resolve : 2) Patient is able to eat :      - multiple-dose schedule : use combination of        short/rapid-acting + intermediate/long-acting RI      - continue IV insulin infusion for 1-2 hr after the          spit-mixed regimen      - DM : insulin dose = before the onset of DKA/HHS      - new Dx DM : 0.5-1 units/kg/day divide two doses          regimen of short + long-acting RI       - type-2 DM : oral antihyperglycemic agent & diet
POTASSIUM : • Insulin Rx, correct ȃ & volume expansion  HypoK • Prevent hypoK : replace K < 5.5 mEq/l  &                             adequate urine output • General 20-30 mEq K (2/3 KCl + 1/3 KPO4 ) in each     liter of  infusion fluid   keep serum K = 4-5 mEq/l • hypoK  (< 3.3 mEq/l) :        - K replacement  begin with fluid Rx       - insulin Rx delayed until K > 3.3 mEq/l
BICARBONATE : • controversial • keep pH > 7 for        - reestrablish insulin activity blocks lipolysis       - resolve ketoacidosis without add HCO3   • if pH < 6.9  100 mmol NaHCO3 in 400 ml sterile                           iv rate 200 ml/hr   • if pH 6.9-7.0   50 mmol NaHCO3  in 200 ml sterile                               iv rate 200 ml/hr   • if pH > 7.0   no NaHCO3        • mornitor venous pH q 2 hr until pH > 7.0    • caution : hypoK NaHCO3  in NaCl not Na > 155 mEq/l
PHOSPHATE :  Whole-body phosphate deficit in DKA = 1 mmol/kg Serum phosphate decrease with insulin Rx  I/C phosphate replacement        • cardiac dysfunction        • anemia       • respiratory depression Serum phosphate < 1 mg/dl  20-30 mEq/l K2PO4   No Rx phosphate in HHS Over phosphate Rx  hypoCa without tetany
COMPLICATIONS : ● hypoglycemia : over insulin Rx ● hypoK : insulin Rx & Rx acidosis with NaHCO3  ● hyperglycemia : interrupt/stop iv insulin after     recovery without subsequent sc insulin ● hyperchloremia : excessive saline for fluid &  E’lyte replacement
COMPLICATION : ● transient non-anion gap metabolic acidosis     (except acute renal failure or extreme oliguria) ● hypoxemia & noncardiogenic pulmonary edema    be careful in widen A-a oxygen gradient
COMPLICATION : ● Cerebral edema from osmolality :       - rapid alteration of consciousness      - headache                   - seizure         - incontinence              - bradycardia      - pupillary changes      - rapid papilledema      - respiratory arrest ☺ prevent by gradual replacement of Na & water         deficit in hyperosmolality        (max ↓ 3 mOsm/kg/hr)     ☺ In HHS : keep BS 250-300 mg/dl until  hyperosmolality & mental status improve
PREVENTION : Check up or F/U Pt education   BS goals & use short-acting RI during illness  self monitor  if BS > 300 mg/dl   be careful suppress fever & Rx infection 6)Early recovery : take easily digestible liquid diet       (carbohydrate + salt)

Mais conteúdo relacionado

Mais procurados

Hyperglycemic crisis ppt.
Hyperglycemic crisis ppt.Hyperglycemic crisis ppt.
Hyperglycemic crisis ppt.mornii
 
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/Cường Hoàng
 
Hyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitusHyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitusKapil Dhingra
 
Diabetic Ketoacidosis. A Review
Diabetic Ketoacidosis. A ReviewDiabetic Ketoacidosis. A Review
Diabetic Ketoacidosis. A ReviewSujay Iyer
 
Potassium imbalance and management
Potassium imbalance and managementPotassium imbalance and management
Potassium imbalance and managementcharithwg
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic KetoacidosisEBMGoneWild
 
Metabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusMetabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusNikhil Chougule
 
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALIDRooma Khalid
 
Aki an overview
Aki an overviewAki an overview
Aki an overviewFAARRAG
 
Management of diabetic ketoacidosis
Management of diabetic ketoacidosisManagement of diabetic ketoacidosis
Management of diabetic ketoacidosisNgọc Anh Lương
 
Hyperglycemic hyperosmolar state hhs
Hyperglycemic hyperosmolar state hhsHyperglycemic hyperosmolar state hhs
Hyperglycemic hyperosmolar state hhsMEEQAT HOSPITAL
 
Metabolic emergencies of diabetis mellitus
Metabolic emergencies of diabetis mellitusMetabolic emergencies of diabetis mellitus
Metabolic emergencies of diabetis mellitusPrudhvi Krishna
 
Diabetic Emergencies
Diabetic EmergenciesDiabetic Emergencies
Diabetic Emergenciesnawan_junior
 
Diabetic ketoacidosis/DKA
Diabetic ketoacidosis/DKADiabetic ketoacidosis/DKA
Diabetic ketoacidosis/DKAAmit Shekharay
 

Mais procurados (20)

Hyperglycemic crisis ppt.
Hyperglycemic crisis ppt.Hyperglycemic crisis ppt.
Hyperglycemic crisis ppt.
 
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
 
Hyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitusHyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitus
 
Diabetic Ketoacidosis. A Review
Diabetic Ketoacidosis. A ReviewDiabetic Ketoacidosis. A Review
Diabetic Ketoacidosis. A Review
 
DIABETIC KETOACIDOSIS GUIDELINES
DIABETIC KETOACIDOSIS GUIDELINESDIABETIC KETOACIDOSIS GUIDELINES
DIABETIC KETOACIDOSIS GUIDELINES
 
Potassium imbalance and management
Potassium imbalance and managementPotassium imbalance and management
Potassium imbalance and management
 
JOURNAL diabetic ketoacidosis
JOURNAL  diabetic ketoacidosisJOURNAL  diabetic ketoacidosis
JOURNAL diabetic ketoacidosis
 
Dka & hhs
Dka & hhsDka & hhs
Dka & hhs
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
Metabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusMetabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitus
 
Management of hyperkalemia in ckd
Management of hyperkalemia in ckdManagement of hyperkalemia in ckd
Management of hyperkalemia in ckd
 
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
 
Diabetic keto acidosis ppt
Diabetic keto acidosis pptDiabetic keto acidosis ppt
Diabetic keto acidosis ppt
 
Diabetic ketoacidosis
Diabetic ketoacidosisDiabetic ketoacidosis
Diabetic ketoacidosis
 
Aki an overview
Aki an overviewAki an overview
Aki an overview
 
Management of diabetic ketoacidosis
Management of diabetic ketoacidosisManagement of diabetic ketoacidosis
Management of diabetic ketoacidosis
 
Hyperglycemic hyperosmolar state hhs
Hyperglycemic hyperosmolar state hhsHyperglycemic hyperosmolar state hhs
Hyperglycemic hyperosmolar state hhs
 
Metabolic emergencies of diabetis mellitus
Metabolic emergencies of diabetis mellitusMetabolic emergencies of diabetis mellitus
Metabolic emergencies of diabetis mellitus
 
Diabetic Emergencies
Diabetic EmergenciesDiabetic Emergencies
Diabetic Emergencies
 
Diabetic ketoacidosis/DKA
Diabetic ketoacidosis/DKADiabetic ketoacidosis/DKA
Diabetic ketoacidosis/DKA
 

Destaque

Destaque (9)

Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managment
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKA
 
ESRD and DKA
ESRD and DKAESRD and DKA
ESRD and DKA
 
Dka Vs Hhs Suraya
Dka Vs Hhs  SurayaDka Vs Hhs  Suraya
Dka Vs Hhs Suraya
 
DKA pathophysiology
DKA pathophysiologyDKA pathophysiology
DKA pathophysiology
 
DKA and HHS
DKA and HHSDKA and HHS
DKA and HHS
 
DKA FINAL
DKA FINALDKA FINAL
DKA FINAL
 
Hyperglycemic emergency
Hyperglycemic emergencyHyperglycemic emergency
Hyperglycemic emergency
 
Dka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copyDka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copy
 

Semelhante a Dka presentation1

DKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxDKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxradhashelly
 
DKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosisDKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosisnanikhelma
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDr.Mansoor Elahi
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenCSN Vittal
 
Diabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxDiabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxRana Shankor Roy
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic KetoacidosisSof2050
 
MANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxMANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxAnkit Kumar
 
ACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencyACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencytaem
 
dkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxdkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxAhmedMandour37
 
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxDKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxAhmedMandour37
 
dkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfdkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfHarisAliKhan22
 
Management of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSManagement of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSSurabhi Yadav
 
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. KasyapaAcute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. KasyapaVeerabhadra Kasyapa J
 
Dka pathphysiologymanagement2014-copy-140202235658-phpapp02
Dka pathphysiologymanagement2014-copy-140202235658-phpapp02Dka pathphysiologymanagement2014-copy-140202235658-phpapp02
Dka pathphysiologymanagement2014-copy-140202235658-phpapp02Wael Eladl
 

Semelhante a Dka presentation1 (20)

DKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxDKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptx
 
DKA.pptx
DKA.pptxDKA.pptx
DKA.pptx
 
DKA .pdf
DKA .pdfDKA .pdf
DKA .pdf
 
DKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosisDKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosis
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in Children
 
Diabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxDiabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptx
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
DKA.pptx
DKA.pptxDKA.pptx
DKA.pptx
 
MANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxMANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptx
 
ACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencyACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergency
 
dkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxdkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptx
 
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxDKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
 
dkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfdkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdf
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
Management of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSManagement of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUS
 
Diabetic Crises
Diabetic CrisesDiabetic Crises
Diabetic Crises
 
DKA and HHS
DKA and HHSDKA and HHS
DKA and HHS
 
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. KasyapaAcute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
 
Dka pathphysiologymanagement2014-copy-140202235658-phpapp02
Dka pathphysiologymanagement2014-copy-140202235658-phpapp02Dka pathphysiologymanagement2014-copy-140202235658-phpapp02
Dka pathphysiologymanagement2014-copy-140202235658-phpapp02
 

Último

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 

Último (20)

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

Dka presentation1

  • 1.
  • 2. PATHOGENESIS BOTH : insulin deficiency + elevation of counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone) ↓ Increase hepatic & renal glucose production Impaired glucose utilization in peripheral tissues ↓ Hyperglycemia & increase plasma osmolality
  • 3. PATHOGENESIS DKA : release of free fatty acids (lipolysis) ↓ Hepatic fatty acid oxidation to ketone bodies (β-hydroxybutyrate & acetoacetate) ↓ Ketonemia & metabolic acidosis
  • 4. PATHOGENESIS HHS : Plasma insulin – inadequate for glucose utilization ‒ adequate to prevent lipolysis & ketogenesis DKA & HHS : ― magnitude of dehydration ― degree of ketosis (& acidosis)
  • 5. PRECIPITATING FACTORS ● Infection ● Cerebrovascular accident ● Alcohol abuse ● Pancreatitis ● Myocardial infarction ● Trauma ● Drugs e.g. steroids, thiazides, sympathomimetic agents (dobutamine & terbutaline) ● Stop/inadequate insulin in DM type I ● Elderly with new-onset DM
  • 6.
  • 7. DIAGNOSIS History & physical examination : Process : - HHS : over several days to weeks - DKA : much shorter (typically < 24 hr) 2) Classical clinical picture of both : - polyuria - polydipsia - polyphagia - weight loss - vomitting - abdominal pain (DKA) - dehydration - weakness - clouding of sensoria - coma
  • 8. DIAGNOSIS 3) Physical finding : - poor skin tugor - Kussmaul respiration (DKA) - tachycardia - hypotension - alteration of conscious (lethargy  coma :HHS) - emesis (coffee-ground) - hypothermia (peripheral vasodilatation) - abdominal pain (DKA : Rx dehydration & metabolic acidosis)
  • 9. LABORATORY FINDINGS : 1)Initial lab : - BS, BUN, Cr, serum ketone - electrolyte (with calculated anion gap) •pseudohypoNa : osmotic gradient from hypergly. • true hypoNa from severe hyperTG • hyperK from insulin deficiency,hypotonicity& acidemia(cell shift) - osmolality : ≥ 320 mOsm/kg  stupor/coma = 2 [measured Na (mEq/L) + BS (mg/dl)/18) - CBC with diff count (leukocytosisὰ serum ketone) - U/A, urine ketone
  • 10. LABORATORY FINDINGS : 1)Initial lab: - EKG - HbA1C : acute or chronic poor control 2) Suspected infection : - bacterial cultures of urine,blood & throat ,etc - CxR - abdominal pain : pancreatitis  serum lipase (DKA : increase serum amylase & liver enz )
  • 11. DIFFERENTIAL DIAGNOSIS : Ketoacidosis: - Starvation ketosis - Alcoholic ketoacidosis mildly elevation BS (rarely > 250 mg/dl) serum HCO3 not < 18 mEQ/L 2) High-anion gap metabolic acidosis : - Lactic acidosis (Ix : serum lactate) - drugs : • salicylate (Ix : serum salicylate), • methanol (Ix : serum methanol) • ethylene glycol (Ix : U/A-calcium oxalate &hippurate crystal),
  • 12. DIFFERENTIAL DIAGNOSIS : 2) High-anion gap metabolic acidosis : - paraldehyde (strong odor breathing-osmolar gap- anion gap acidosis) - Chronic renal failure (hyperchloremic acidosis)
  • 13. TREATMENT : Correction of dehydration, hyeprglycemia & E’lyte imbalance 2) Correct precipitating factor 3) Guideline for management
  • 14. Fluid therapy : Adult patients : - initial fluid Rx in no cardiac compromise : 0.9%NaCl ≥ 15-20 ml/kg/hr in 1st hour ( ~ 1-1.5 L ) - subsequent choice for fluid depend on hydration, serum E’lyte & urine output • if N/↑serum Na  0.45% NaCl 4 – 14 ml/kg • if ↓ serum Na  0.9% NaCl - monitor BP; fluid input/output ; clinical exam ; sermoosmolality not > 3 mOsm/kg/H2O/hr - fluid replacement correct deficit in 24 hr
  • 15. FLUID THERAPY : 2) Pediatric patients (< 20 yrs) : - 1st hr : 0.9%NaCl 10-20 ml/hr ( not > 50 ml/kg in first 4 hr of therapy ) - Continued fluid therapy = fluid deficit in 48 hr or 1.5 times of 24 hr maintenance or 5 ml/kg/hr • 0.45-0.9% NaCl rate • ↓ osmolality not > 3 mOsm/kg/hr - serum glucose = 250 mg/dl  change 5%DN/2 or 5%D/N/3 with potassium
  • 16.
  • 17. INSULIN THERAPY : Not mild DKA : Rx of choice = regular insulin continuous IV infusion Exclude hypoK (< 3.3 mEq/l) Start regular insulin 0.15 units/kg iv bolus (iv bolus nit recommend in pediatric) Cont. infusion 0.1 units/kg/hr (5-7 units/hr in adult) Aim decrease BS 50-75 mg/dl/hr If in 1st hr BS not decrease > 50 mg/dl • check hydration • double dose insulin infusion every hr
  • 18. INSULIN THERAPY : when BS = 250 mg/dl in DKA or = 300 mg/dl in HHS • ↓ insulin infusion rate = 0.05 - 0.1 unit/kg/hr (3-6 units/hr) • 5-10% Dextrose Keep until acidosis in DKA mental status hyperosmolarity in HHS  resolve
  • 19. INSULIN THERAPY : Ketonemia • longer ot clear than hyperglycemia • monitor by measure serum β-OHB during Rx β-OHB  acetoacetic ȃ  worse ketosis then not use urine / serum ketone level for Rx During Rx : monitor serum E’lyte , BS, BUN, Cr, osmolality & venous pH (for DKA) q 2-4 hr ( venous pH < arterial pH = 0.03 units ) anion gap  resolution of acidosis
  • 20. Mild DKA : Regular insulin SC or IM q 1 hr - priming dose of RI = 0.4 – 0.6 unit/kg • half  IV bolus • half  SC or IM - then RI 0.1 unit/kg/hr SC or IM
  • 21.
  • 22.
  • 23.
  • 24. CRITERIA FOR RESOLUTION OF DKA : ● Glucose < 200 mg/dl ● Serum bicarbonate ≥ 18 mEq/l ● Venous pH > 7.3 When DKA resolve If NPO : • continue IV insulin & fluid replacement • RI sc q 4 hr (RI 5 unit / BS 50 mg/dl if BS > 150 mg/dl until RI 20 unit for BS ≥ 300 mg/dl)
  • 25. When DKA resolve : 2) Patient is able to eat : - multiple-dose schedule : use combination of short/rapid-acting + intermediate/long-acting RI - continue IV insulin infusion for 1-2 hr after the spit-mixed regimen - DM : insulin dose = before the onset of DKA/HHS - new Dx DM : 0.5-1 units/kg/day divide two doses regimen of short + long-acting RI - type-2 DM : oral antihyperglycemic agent & diet
  • 26. POTASSIUM : • Insulin Rx, correct ȃ & volume expansion  HypoK • Prevent hypoK : replace K < 5.5 mEq/l & adequate urine output • General 20-30 mEq K (2/3 KCl + 1/3 KPO4 ) in each liter of infusion fluid  keep serum K = 4-5 mEq/l • hypoK (< 3.3 mEq/l) : - K replacement begin with fluid Rx - insulin Rx delayed until K > 3.3 mEq/l
  • 27. BICARBONATE : • controversial • keep pH > 7 for - reestrablish insulin activity blocks lipolysis - resolve ketoacidosis without add HCO3 • if pH < 6.9  100 mmol NaHCO3 in 400 ml sterile iv rate 200 ml/hr • if pH 6.9-7.0  50 mmol NaHCO3 in 200 ml sterile iv rate 200 ml/hr • if pH > 7.0  no NaHCO3 • mornitor venous pH q 2 hr until pH > 7.0 • caution : hypoK NaHCO3 in NaCl not Na > 155 mEq/l
  • 28. PHOSPHATE : Whole-body phosphate deficit in DKA = 1 mmol/kg Serum phosphate decrease with insulin Rx I/C phosphate replacement • cardiac dysfunction • anemia • respiratory depression Serum phosphate < 1 mg/dl  20-30 mEq/l K2PO4 No Rx phosphate in HHS Over phosphate Rx  hypoCa without tetany
  • 29. COMPLICATIONS : ● hypoglycemia : over insulin Rx ● hypoK : insulin Rx & Rx acidosis with NaHCO3 ● hyperglycemia : interrupt/stop iv insulin after recovery without subsequent sc insulin ● hyperchloremia : excessive saline for fluid & E’lyte replacement
  • 30. COMPLICATION : ● transient non-anion gap metabolic acidosis (except acute renal failure or extreme oliguria) ● hypoxemia & noncardiogenic pulmonary edema be careful in widen A-a oxygen gradient
  • 31. COMPLICATION : ● Cerebral edema from osmolality : - rapid alteration of consciousness - headache - seizure - incontinence - bradycardia - pupillary changes - rapid papilledema - respiratory arrest ☺ prevent by gradual replacement of Na & water deficit in hyperosmolality (max ↓ 3 mOsm/kg/hr) ☺ In HHS : keep BS 250-300 mg/dl until hyperosmolality & mental status improve
  • 32. PREVENTION : Check up or F/U Pt education BS goals & use short-acting RI during illness self monitor  if BS > 300 mg/dl  be careful suppress fever & Rx infection 6)Early recovery : take easily digestible liquid diet (carbohydrate + salt)